Colorectal cancer patient on maintenance dialysis successfully treated with cetuximab

Anti-Cancer Drugs

Volumn 25, Issue 1, 2014, Pages 120-122

  Fontana, Elisa ^a   Pucci, Francesca ^a   Ardizzoni, Andrea ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

Cetuximab; Colorectal cancer; Hemodialysis

Indexed keywords

CETUXIMAB;

ACNE; AGED; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DISEASE COURSE; DRUG EFFICACY; DRUG TOLERABILITY; HEMODIALYSIS PATIENT; HEPATITIS C; HUMAN; HYPERTENSION; MALE; MEDICAL HISTORY; METASTATIC COLORECTAL CANCER; MONOTHERAPY; PELVIC PAIN; PRIORITY JOURNAL; SACRUM; TREATMENT RESPONSE; WILD TYPE;

ADENOCARCINOMA; AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; HUMANS; MALE; RENAL DIALYSIS;

EID: 84889252880     PISSN: 09594973     EISSN: 14735741     Source Type: Journal    
DOI: 10.1097/CAD.0000000000000025     Document Type: Article

References (13)

1. Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 1999; 354:93-99. (Pubitemid 29313142)
2. Stewart JH, Buccianti G, Agodoa L, Gellert R, McCredie MR, Lowenfels AB, et al. Cancers of the kidney and urinary tract in patients on dialysis for endstage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 2003; 14:197-207. (Pubitemid 36026310)
3. Janus N, Thariat J, Boulanger H, Deray G, Launay-Vacher V. Proposal for dosage adjustment and timing of chemotherapy in hemodialyzed patients. Ann Oncol 2010; 21:1395-1403.
4. World Health Organization. Cancer: fact sheet number 297; 2011. Available at: http://www.who.int/mediacentre/factsheets/fs297/en/ [Accessed 27 August 2013].
5. Saidi RF, Dudrick PS, Goldman MH. Colorectal cancer after renal transplantation. Transplant Proc 2003; 35:1410-1412. (Pubitemid 36765546)
6. Collins MG, Teo E, Cole SR, Chan CY, McDonald SP, Russ GR, et al. Screening for colorectal cancer and advanced colorectal neoplasia in kidney transplant recipients: cross sectional prevalence and diagnostic accuracy study of faecal immunochemical testing for haemoglobin and colonoscopy. BMJ 2012; 345:e4657.
7. Iseki K, Osawa A, Fukiyama K. Evidence for increased cancer deaths in chronic dialysis patients. Am J Kidney Dis 1993; 22:308-313. (Pubitemid 23236639)
8. Venat-Bouvet L, Saint-Marcoux F, Lagarde C, Peyronnet P, Lebrun-Ly V, Tubiana Mathieu N. Irinotecan-based chemotherapy in a metastatic colorectal cancer patient under haemodialysis for chronic renal dysfunction: two cases considered. Anticancer Drugs 2007; 18:977-980. (Pubitemid 47220719)
9. Stemmler J, Weise A, Hacker U, Heinemann V, Schalhorn A. Weekly irinotecan in a patient with metastatic colorectal cancer on hemodialysis due to chronic renal failure. Onkologie 2002; 25:60-63. (Pubitemid 34224995)
10. Jonker DJ, O'Callaghan CJ, Karapetis CS, Zalcberg JR, Tu D, Au HJ, et al. Cetuximab for the treatment of colorectal cancer. N Engl J Med 2007; 357:2040-2048. (Pubitemid 350106711)
11. Thariat J, Azzopardi N, Peyrade F, Launay-Vacher V, Santini J, Lecomte T, et al. Cetuximab pharmacokinetics in end-stage kidney disease under hemodialysis. J Clin Oncol 2008; 26:4223-4225.
12. Aldoss IT, Plumb T, Zhen W, Lydiatt DD, Ganti AK. Cetuximab in hemodialysis: a case report. Head Neck 2009; 31:1647-1650.
13. Inauen R, Cathomas R, Boehm T, Koeberle D, Pestalozzi BC, Gillessen S, et al. Feasibility of using cetuximab and bevacizumab in a patient with colorectal cancer and terminal renal failure. Oncology 2007; 72:209-210. (Pubitemid 351161612)